Skip to main content

Table 1 Selection details for analyzed tumor sites/entities for the three cancer registries and selected incidence data. low, +high incidence. 1: male/female; age 60 for SEER-9 and age group 60–64 otherwise

From: An R package for an integrated evaluation of statistical approaches to cancer incidence projection

registry

entity/site

selection

#cases1

 
   

1990

2014

SEER-9

Glioblastoma

HISTO3V: 9440

13/7

21/14

Kidney cancer

PRIMSITE: C649

35/23

99/45

Melanoma

PRIMSITE: C440–449

54/36

227/144

Lung and bronchial tumors+

PRIMSITE: C340–349

263/169

221/183

Breast cancer+

PRIMSITE: C500–509

4/404

2/845

Colorectal cancer+

PRIMSITE: C18–20

151/100

182/120

Prostate cancer+

PRIMSITE: C61.9

250

595

NORDCAN

Brain, central nervous system

cancer: 340

194/192

299/309

Kidney

cancer: 290

182/118

343/158

Melanoma of skin

cancer: 310

182/157

551/447

Lung+

cancer: 180

929/411

906/900

Breast+

cancer: 200

9/1314

21/2877

Colorectal+

cancer: 590

638/551

1148/872

Prostate+

cancer:261

762

3878

Saarland

Brain tumors [Gehirn] -

loc: 191

2/2

8/2

Kidney cancer [Niere, sonst.u.n.n.bez. Harnorgane] -

loc: 189

18/9

13/6

Melanoma [Bösartiges Melanom der Haut] -

loc: 712

3/6

15/10

Lung, bronchial and tracheal tumors [Luftröhre, Bronchien u. Lunge] +

loc: 162

109/14

86/46

Female breast tumors [Weibliche Brustdrüse] +

loc: 174

75

107

Colorectal cancer [Dick- und Mastdarm] +

loc: 153 + 154

47/49

59/36

Prostate cancer [Prostata] +

loc: 185

36

95